Orciprenaline sulphate

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 17.11.2022

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Half-life
This section has been translated automatically.

6 h

Indication
This section has been translated automatically.

Bronchial asthma (status asthmaticus), antidote for relative and absolute overdose of beta-receptor blockers, bradycardic excitation and conduction disorders.

Limited indication
This section has been translated automatically.

Pregnancy last weeks (inhibition of contractions!), lactation, poorly controlled diabetes mellitus, mitralvitium, myocarditis, tachyarrhythmias, WPW syndrome.

Dosage and method of use
This section has been translated automatically.

  • Cardiology: 0.5-1 amp. slow i.v.; 1-2 amp. i.m. or s.c.
  • Pneumology: adult: 1-2 Amp. i.m. or s.c. possibly also 0.5 Amp. very slowly i.v.

Standard concentration
This section has been translated automatically.

3-4 times/day 1-2 strokes of 0.75 mg, max. 12 strokes/day.

Undesirable effects
This section has been translated automatically.

Allergic reactions, contractions, hyperhidrosis, sleep disturbances, angina, RR drop, extrasystoles, purpura, thrombocytopenia, paradoxical bronchospasm, micturition disorders.

Interactions
This section has been translated automatically.

Blood sugar lowering effect of antidiabetics is reduced.

Contraindication
This section has been translated automatically.

Preparations
This section has been translated automatically.

Alupent

Incoming links (1)

Hyperhidrosis, drug-induced;

Authors

Last updated on: 17.11.2022